Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Tool Provides Reliable Method for Identifying Pathogens

By LabMedica International staff writers
Posted on 15 Dec 2023

The overuse of antibiotics globally has led to an increase in antibiotic-resistant bacteria, making the treatment of bacterial diseases increasingly challenging. More...

Antibiotics are a crucial tool in combating these infections, and reducing their usage is essential. To aid in this effort, researchers have devised a new method for identifying bacteria that is simpler, less expensive, and more accurate than previous techniques. This advancement could play a significant role in reducing antibiotic use.

The new method developed by an international research group led by the Norwegian University of Science and Technology (NTNU, Trondheim, Norway) is faster because it eliminates the need for 'gene amplification'. This traditional step, which involves creating multiple copies of genetic material for easier analysis, is no longer necessary. The innovative method focuses on detecting short DNA sequences of bacteria. It achieves this by observing the binding of these sequences to various DNA variants are grafted onto colloids – particles suspended in a liquid.

This approach allows for rapid bacterial identification by analyzing how different bacteria bind to these colloids, causing the, to clump together. The advantage here is the reduced need for analyzing large volumes of genetic material and the ability to bypass the gene copying process. This results in time and cost savings. While this method is still in the early stages of development, it holds significant potential, especially in a context where antibiotic resistance is a growing concern. More work is needed to bring this method into mainstream usage

“We have developed a simple tool that can identify all of the genetic material in bacteria,” said Professor Erika Eiser at NTNU’s Department of Physics. “This allows us to find out more quickly what kind of bacteria a sick person or animal is affected by, or what kind of bacteria are found in food or the environment. We can then also decide whether it is necessary to use antibiotics against the bacterium, and if so what kind, so we don’t have to use as much medication.”

Related Links:
NTNU 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Laboratory Software
ArtelWare
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.